Skip to the content Skip to the Navigation

ClinChoice

  • About ClinChoice
    • Top Message・Corporate Philosophy
    • Company Profile・Our History
    • Leadership Team
    • Group Investors/Group Partners
  • Service Offering
    • Service Sector
      • Regulatory Affairs
      • Clinical Operation
      • Data Management
      • Statistical Analysis/Programming
      • Medical Writting
      • Pharmacovigilance
      • Medical Affairs
      • Clinical Coordinator Office
      • Development Strategy / Regulatory Consulting
      • Drug Master File (DMF) Application
    • Clinical Solutions
      • Clinical Development in China
      • Multicenter Randomized Clinical Trial (MRCT)
      • Investigator Initiated Trial (IIT)
      • Development on Traditional Medicine and Food for Specified Health Uses (FOSHU)
      • Dispatch Business
      • Clinical Development Network in China
      • Clinical Trial in Southeast Asia
  • News
  • Recruitment
  • Group Network
  • Contact
  • JP

Group

  1. HOME
  2. News
  3. Group
2024年12月2日 / Last updated : 2024年12月2日 fmdkljp Group

Double award: “Top 100 Chinese Life Science Service Companies Brand 2024” and “Top 20 CROs in Clinical Operations for Drug Registration in China”

Consecutive Selection for the “2024 China Life Science Service Enterprise Brand Top 100” ClinChoice Group has been honored with a consecutive selection for the prestigious “2024 China Life Science Service Enterprise Brand Top 100.” Leveraging its outstanding service capabilities and brand influence, ClinChoice has firmly secured this recognition once again. The ranking evaluates enterprises comprehensively […]

2024年9月17日 / Last updated : 2024年9月17日 Admin-EN Group

ClinChoice Wins The Asset’s 2024 Award for Best Liquid Funds Management Solution in Healthcare

Recently, The Asset, an authoritative international financial media, announced the list of winners of the 2024 Triple A Treasuries Awards, and ClinChoice was honored with the “Best Liquidity Funds Management Solution in Healthcare” for its excellent financial management system. This not only highlights our leading position in the healthcare sector, but also illustrates the continuous […]

2024年9月17日 / Last updated : 2024年9月17日 Admin-EN Group

Gather at 2024 DIA Annual Meeting to Draw a Blueprint for the Industry

With the booming development of global biopharmaceutical field, the annual meeting of Drug Information International (DIA) has become an important platform for communication, cooperation, and innovation in the industry. ClinChoice, as a leader in the field of CRO, will attend this meeting. We will display our innovative achievements and comprehensive strength in Hall C, M05. […]

  • All
  • News
  • Notice
  • Group
  • Regulatory Watch

Japan
3F, VORT HigashiNihonbashi 2,HigashiNihonbashi 3-4-1,Chuo Ku, Tokyo,〒103-0004,Japan
TEL: 03-6228-7360
FAX: 03-6701-2398

CHINA
11F Building A, Fenglin International Tower,
420 Fenglin Road,
Xuhui District, 200032, Shanghai

U.S.A
300 Welsh Road Building 5, Suite 201 Horsham, PA 19044 USA

Company Profile

  • Top Message・Corporate Philosophy
  • Company Profile・Our History
  • Leadership Team
  • Group Investors/Group Partners
  • Recruitment
  • Group Network
  • Contact
  • Privacy Policy

Service Sector

  • Regulatory Affairs
  • Clinical Operation
  • Data Management
  • Statistical Analysis/Programming
  • Medical Writting
  • Pharmacovigilance
  • Medical Affairs
  • Clinical Coordinator Office
  • Development Strategy / Regulatory Consulting
  • Drug Master File (DMF) Application

Development Needs

  • Clinical Development in China
  • Multicenter Randomized Clinical Trial (MRCT)
  • Investigator Initiated Trial (IIT)
  • Dispatch Business
  • Development on Traditional Medicine and Food for Specified Health Uses (FOSHU)
  • Clinical Development Network in China

Copyright © ClinChoice All Rights Reserved.

Powered by WordPress with Lightning Theme & VK All in One Expansion Unit

MENU
  • About ClinChoice
    • Top Message・Corporate Philosophy
    • Company Profile・Our History
    • Leadership Team
    • Group Investors/Group Partners
  • Service Offering
    • Service Sector
      • Regulatory Affairs
      • Clinical Operation
      • Data Management
      • Statistical Analysis/Programming
      • Medical Writting
      • Pharmacovigilance
      • Medical Affairs
      • Clinical Coordinator Office
      • Development Strategy / Regulatory Consulting
      • Drug Master File (DMF) Application
    • Clinical Solutions
      • Clinical Development in China
      • Multicenter Randomized Clinical Trial (MRCT)
      • Investigator Initiated Trial (IIT)
      • Development on Traditional Medicine and Food for Specified Health Uses (FOSHU)
      • Dispatch Business
      • Clinical Development Network in China
      • Clinical Trial in Southeast Asia
  • News
  • Recruitment
  • Group Network
  • Contact
  • JP
PAGE TOP